Bausch Health Companies BHC
NYSE BHC
$6.16 -0.26 (-4.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) Deferred Taxes (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Deferred Taxes came in at $17.0 million in Q2 2026, up 140.48% year-over-year from $7.1 million in Q2 2025, and down 43.33% quarter-over-quarter from $30.0 million in Q1 2026.

Analysis

Bausch Health Companies (BHC) Deferred Taxes (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Deferred Taxes across 18 years of filings, most recently posting $17.0 million for Q2 2026.

  • In Q2 2026, Deferred Taxes rose 140.48% year-over-year to $17.0 million; the TTM figure through Jun 2026 stood at $178.0 million (up 53.45% YoY), while the FY2025 annual figure was $80.0 million, up 21.21% from the prior year.
  • Deferred Taxes came in at $17.0 million for Q2 2026 at Bausch Health Companies, down from $30.0 million in the prior quarter.
  • In the past five years, Deferred Taxes ranged from a high of $170.0 million in Q4 2024 to a low of -$96.0 million in Q3 2022.
  • Average Deferred Taxes over 5 years is $4.0 million, with a median of -$9.0 million recorded in 2025.
  • Year-over-year, Deferred Taxes plunged 700.0% in 2025 and jumped 433.33% in 2026.
  • Over 5 years, Deferred Taxes stood at $19.0 million in 2022, then soared by 342.11% to $84.0 million in 2023, then soared by 102.38% to $170.0 million in 2024, then dropped by 8.82% to $155.0 million in 2025, then sank by 89.03% to $17.0 million in 2026.
  • Per Business Quant data, the three most recent Deferred Taxes figures were $17.0 million in Q2 2026, $30.0 million in Q1 2026, and $155.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn 25.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -124.50 Mn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 12.44 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn -
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 17.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn 59,000.00
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn -4.94 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn -
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn -
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.00 Mn
Mar 31, 2026 30.00 Mn
Dec 31, 2025 155.00 Mn
Sep 30, 2025 -24.00 Mn
Jun 30, 2025 -42.00 Mn
Mar 31, 2025 -9.00 Mn
Dec 31, 2024 170.00 Mn
Sep 30, 2024 -3.00 Mn
Jun 30, 2024 -44.00 Mn
Mar 31, 2024 -57.00 Mn
Dec 31, 2023 84.00 Mn
Sep 30, 2023 -3.00 Mn
Jun 30, 2023 -30.00 Mn
Dec 31, 2022 19.00 Mn
Sep 30, 2022 -96.00 Mn
Jun 30, 2022 -16.00 Mn
Mar 31, 2022 -83.00 Mn
Dec 31, 2021 -88.00 Mn
Sep 30, 2021 -17.00 Mn
Jun 30, 2021 -106.00 Mn